Trial intelligence / Profile preview

RCP in Newly Diagnosed Multiple Myeloma

NCT00540644Phase 2Completed

Start
Oct 2007
Primary completion
Dec 2012
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of lenalidomide in multiple myeloma (MM). Started Oct 2007; status: completed.

02

Drugs

lenalidomide
03

Conditions

multiple myeloma (MM)

Beyond the preview

Go deeper on NCT00540644.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00540644.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call